Rep. Steve Cohen sold Emergent BioSolutions (EBS)
Rep. Steve Cohen (D-TN-9) · $1K–$15K · traded Dec 11, 2024
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Dec 11, 2024
- Disclosed
- Jan 10, 2025
- Days to disclose
- 30
- Asset type
- Stock
- As filed
- Emergent BioSolutions Inc. Common Stock
- Industry
- Drug Manufacturers - Specialty & Generic · Healthcare
Other trades in this filing
- Jan 10, 2025$15K–$50K
Sold Host Hotels & Resorts HST
$15K–$50K · Traded Dec 11, 2024 · disclosed Jan 10, 2025
Company context for EBS
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
EBS: third_quarter 2026 lobbying report
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical de
Public: Oct 19, 2026, 4:27 PM EDTOriginal source ↗EBS: third_quarter 2026 lobbying report
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and che
Public: Oct 13, 2026, 3:57 PM EDTOriginal source ↗EBS: second_quarter 2026 lobbying report
Reauthorization of Protecting Americans from All-Hazards Preparedness Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY27; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27; Tribal Opioid Response Grant funding for FY27; H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical de
Public: Jul 19, 2026, 11:16 AM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.